- Home
- RGNX vs SWBI Comparison
RGNX vs SWBI Comparison
Compare RGNX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- SWBI
- Stock Information
- Founded
- RGNX 2008
- SWBI 1852
- Country
- RGNX United States
- SWBI United States
- Employees
- RGNX N/A
- SWBI N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- SWBI Ordnance And Accessories
- Sector
- RGNX Health Care
- SWBI Industrials
- Exchange
- RGNX Nasdaq
- SWBI Nasdaq
- Market Cap
- RGNX 451.1M
- SWBI 429.0M
- IPO Year
- RGNX 2015
- SWBI N/A
- Fundamental
- Price
- RGNX $9.26
- SWBI $9.39
- Analyst Decision
- RGNX Strong Buy
- SWBI Buy
- Analyst Count
- RGNX 8
- SWBI 2
- Target Price
- RGNX $28.50
- SWBI $12.00
- AVG Volume (30 Days)
- RGNX 528.4K
- SWBI 1.2M
- Earning Date
- RGNX 11-05-2025
- SWBI 09-04-2025
- Dividend Yield
- RGNX N/A
- SWBI 5.52%
- EPS Growth
- RGNX N/A
- SWBI N/A
- EPS
- RGNX N/A
- SWBI 0.26
- Revenue
- RGNX $155,782,000.00
- SWBI $471,404,000.00
- Revenue This Year
- RGNX $203.27
- SWBI N/A
- Revenue Next Year
- RGNX $0.58
- SWBI $2.44
- P/E Ratio
- RGNX N/A
- SWBI $35.82
- Revenue Growth
- RGNX 74.95
- SWBI N/A
- 52 Week Low
- RGNX $5.04
- SWBI $7.73
- 52 Week High
- RGNX $13.48
- SWBI $14.20
- Technical
- Relative Strength Index (RSI)
- RGNX 52.58
- SWBI 53.75
- Support Level
- RGNX $8.82
- SWBI N/A
- Resistance Level
- RGNX $10.08
- SWBI $9.77
- Average True Range (ATR)
- RGNX 0.55
- SWBI 0.35
- MACD
- RGNX -0.03
- SWBI -0.21
- Stochastic Oscillator
- RGNX 42.66
- SWBI 96.06
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.